AgomAb Therapeutics ($AGMB) Insider Trading & Smart Money Activity
AgomAb Therapeutics NV ($AGMB) has 6 insider trades and 2 analyst ratings on file. In the last 12 months on the open market, 3 insiders bought ($311.17K) and no insider sold, net +$311.17K.
- Insider buyers (12 mo)
- 3
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- +$311.17K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 2
AGMB insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 6 · $311.17K | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All AGMB insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Epstein David RDirector | Buy (Open-market buy) | 5K sh | $44.50K | -9.7% | — | |||||
| Insider | Knotnerus Tim JasperChief Executive Officer | Buy (Open-market buy) | 5K sh | $43.50K | -0.3% | — | |||||
| Insider | Kemula Pierre Thadee VictorChief Financial Officer | Buy (Open-market buy) | 10K sh | $85.94K | -0.3% | — | |||||
| Insider | Epstein David RDirector | Buy (Open-market buy) | 5K sh | $43.50K | -0.3% | — | |||||
| Insider | Knotnerus Tim JasperChief Executive Officer | Buy (Open-market buy) | 6K sh | $50.88K | +4.6% | — | |||||
| Insider | Epstein David RDirector | Buy (Open-market buy) | 5K sh | $42.85K | +4.6% | — | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $35 | +50.5% | -2.0% | Read | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $35 | +50.5% | -2.0% | Read |
1W / 1M / 6M = how AGMB moved from the trade or filing date.
Insider trading in AGMB: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Epstein David R | Director | 3 | +$130.85K | Oct 8, 2026 | |
| Knotnerus Tim Jasper | Chief Executive Officer | 2 | +$94.38K | Oct 6, 2026 | |
| Kemula Pierre Thadee Victor | Chief Financial Officer | 1 | +$85.94K | Oct 6, 2026 |
Analyst ratings on AGMB
Frequently asked questions
Are AGMB insiders buying or selling?
Over the last 12 months 3 insiders made 6 open-market purchases worth $311.17K and 0 insiders made 0 open-market sales worth $0, a net +$311.17K.
What is the latest insider trade in AGMB?
Epstein David R, Director filed a buy (open-market buy) of 5K sh worth $44.50K on Oct 8, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.